Publications

Division/Center

The health status of adults with epilepsy compared with that of people without chronic conditions.

Pharmacotherapy
Wagner AK, Bungay KM, Kosinski M, Bromfield EB, Ehrenberg BL

National drug policies.

Lancet
Laing RO, Ross-Degnan DG

Assessing the health status of adult patients with epilepsy.

Am J Health Syst Pharm
Wagner AK, Bungay KM, Bromfield EB, Ehrenberg BL

Introduction to pharmacist participation in measuring and monitoring patients' health-related quality of life.

Am J Health Syst Pharm
Bungay KM, Wagner AK

Computer-based drug-utilization review--risk, benefit, or boondoggle?

N. Engl. J. Med.
Soumerai SB, Lipton HL

Pharmacists as agents of change for rational drug therapy.

Int J Technol Assess Health Care
Lipton HL, Byrns PJ, Soumerai SB, Chrischilles EA

The routine use of health-related quality of life measures in the care of patients with epilepsy: rationale and research agenda.

Qual Life Res
Wagner AK, Vickrey BG

Advances in methods for assessing the impact of epilepsy and antiepileptic drug therapy on patients' health-related quality of life.

Qual Life Res
Wagner AK, Keller SD, Kosinski M, Baker GA, Jacoby A, Hsu MA, Chadwick DW, Ware JE

Hemophilia home treatment. Economic analysis and implications for health policy.

Int J Technol Assess Health Care
Ross-Degnan D, Soumerai SB, Avorn J, Bohn RL, Bright R, Aledort LM

The epidemiology of trachoma in rural Kenya. Variation in prevalence with lifestyle and environment. Study Survey Group.

Ophthalmology
Schwab L, Whitfield R, Ross-Degnan D, Steinkuller P, Swartwood J

Are the peers peers?

JAMA
Soumerai SB

Withdrawal of a drug from the market: what should the prescriber do?

JAMA
Ross-Degnan D, Soumerai SB, Fortess EE, Gurwitz JH

Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.

N. Engl. J. Med.
Soumerai SB, McLaughlin TJ, Ross-Degnan D, Casteris CS, Bollini P

Field tests for rational drug use in twelve developing countries.

Lancet
Hogerzeil HV, Bimo , Ross-Degnan D, Laing RO, Ofori-Adjei D, Santoso B, Azad Chowdhury AK, Das AM, Kafle KK, Mabadeje AF

Comment: assessing the quality of pharmaceutical care.

Ann Pharmacother
Bungay KM, Wagner AK

Examining product risk in context. Market withdrawal of zomepirac as a case study.

JAMA
Ross-Degnan D, Soumerai SB, Fortess EE, Gurwitz JH

Influence of knowledge and attitudes on the quality of physicians' transfusion practice.

Med Care
Salem-Schatz SR, Avorn J, Soumerai SB

A controlled trial of educational outreach to improve blood transfusion practice.

JAMA
Soumerai SB, Salem-Schatz S, Avorn J, Casteris CS, Ross-Degnan D, Popovsky MA

Improving choice of prescribed antibiotics through concurrent reminders in an educational order form.

Med Care
Soumerai SB, Avorn J, Taylor WC, Wessels M, Maher D, Hawley SL

A critical analysis of studies of state drug reimbursement policies: research in need of discipline.

Milbank Q
Soumerai SB, Ross-Degnan D, Fortess EE, Abelson J